The Latin America diabetes devices market size was valued at USD 17.21 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.52% from 2024 to 2030. The rising diabetic and geriatric population, widening knowledge about the various treatments available for t... Read More »
March 2024The global digital dental X-ray market size was estimated at USD 953.65 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030. Digital dental X-rays are images of a patient’s teeth and surrounding structures that are utilize... Read More »
March 2024The U.S. diabetes devices market was valued at USD 9.53 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.91% from 2024 to 2030. Major factors contributing to the growth of this region include the increasing geriatric population, growing burden of diabe... Read More »
February 2024The global end of life planning market size was estimated at USD 29.52 billion in 2023 and is projected to grow at a CAGR of 6.5% from 2024 to 2030. Increased awareness and education about end-of-life options and the importance of planning ahead have contributed to the growth of this mar... Read More »
February 2024The global blood glucose monitoring devices market size was estimated at USD 13.43 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.25% from 2024 to 2030. The market is primarily influenced by the growing prevalence of diabetes and growing elderly popu... Read More »
February 2024The Asia Pacific therapeutic respiratory devices market size was estimated at USD 3.9 billion in 2023 and is expected to witness a compound annual growth rate (CAGR) of 7.22% from 2024 to 2030.The rising geriatric population and the widespread occurrence of respiratory diseases, coupled ... Read More »
February 2024The China endoscopy devices market size was estimated at USD 4.3 billion in 2023 and is projected to register a compound annual growth rate (CAGR) of 10.98% from 2024 to 2030. Rise in adoption of endoscopy devices, mainly endoscopes and visualization systems in healthcare settings is sig... Read More »
February 2024The South Korea endoscopy devices market size was estimated at USD 368.09 million in 2023 and is projected to register a compound annual growth rate (CAGR) of 9.48% from 2024 to 2030. The growth in minimally invasive surgical technologies is expected to boost the demand for endoscopic pr... Read More »
February 2024The Asia Pacific cannabidiol market size was estimated at USD 440.5 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 24.1% from 2024 to 2030. The cannabidiol (CBD) market in Asia Pacific is predicted to expand in line with the growing acceptance and lega... Read More »
February 2024The Brazil endoscopy devices market size was valued at USD 469.1 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.80% from 2024 to 2030. Increasing prevalence of various gastrointestinal, cardiovascular, and other target diseases are expected to boost ... Read More »
February 2024The global home blood pressure monitoring devices market size was estimated at USD 1.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.62% from 2024 to 2030. This can be attributed to the easy usage and probability of devices and the need to reduce... Read More »
February 2024The global ambulatory blood pressure monitoring devices market size was valued at USD 1.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2030. The driving factors for this market include the increasing geriatric populatio... Read More »
February 2024The global iliac stent market size was valued at USD 1.03 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2030. Iliac stents are small mesh tubes used to support narrowed iliac arteries. The growth of the market can be attributed to g... Read More »
February 2024The U.S. dental membrane and bone graft substitutes market size was valued at USD 229.6 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030. The U.S. market is expected to witness lucrative growth due to the increasing geriatric popul... Read More »
February 2024The BRIC oral care market size was valued at USD 11.2 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2030. This growth is attributed to the high degree of awareness about oral health, technological advancement in oral care products... Read More »
February 2024The global biomaterial wound dressing market size was valued at USD 6.23 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.46% from 2024 to 2030. The rising prevalence of chronic diseases, the rising geriatric population, and advancements in wound dres... Read More »
February 2024Facial palsy, also known as facial paralysis, is a condition characterized by the inability to control facial muscles due to nerve damage. This results in weakened or drooping facial muscles. It can affect one or both sides of the face and has various causes, including infections, stroke...Read More »
The global automated external defibrillator market size was valued at USD 1.4 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030. This growth is attributed to the increasing installation of automated external defibrillators (AEDs)... Read More »
February 2024The Europe facial injectable market size was estimated at USD 2.88 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2030. A growing focus on physical appearance among consumers has led to a surge in demand for facial injectables in rec... Read More »
February 2024The North America clinical trials market size was estimated at USD 40.9 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.99% from 2024 to 2030. This is attributed to increasing clinical trial cycles, need for novel therapies, a surge in chronic diseas... Read More »
February 2024